DexCom, Inc. (DXCM)
72.92
-0.16
(-0.22%)
USD |
NASDAQ |
Mar 04, 16:00
72.90
-0.02
(-0.03%)
After-Hours: 20:00
DexCom Cash from Investing (TTM) : 536.00M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| BioLife Solutions, Inc. | -71.54M |
| Abbott Laboratories | -2.422B |
| Insulet Corp. | -222.70M |
| Krystal Biotech, Inc. | -58.42M |
| Boston Scientific Corp. | -2.64B |